Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 20.
Article
Ahmed, T;
Nash, A;
Clark, KE;
Ghibaudo, M;
de Leeuw, NH;
Potter, A;
Stratton, R;
... Bozec, L; + view all
(2017)
Combining nano-physical and computational investigations to understand the nature of "aging" in dermal collagen.
International Journal of Nanomedicine
, 12
pp. 3303-3314.
10.2147/IJN.S121400.
|
Ahmed Abdi, B;
Lopez, H;
Karrar, S;
Renzoni, E;
Wells, A;
Tam, A;
Etomi, O;
... Stratton, R; + view all
(2017)
Use of Patterned Collagen Coated Slides to Study Normal and Scleroderma Lung Fibroblast Migration.
Scientific Reports
, 7
, Article 2628. 10.1038/s41598-017-02621-3.
|
Clark, KE;
Lopez, H;
Abdi, BA;
Guerra, SG;
Shiwen, X;
Khan, K;
Etomi, O;
... Stratton, RJ; + view all
(2015)
Multiplex cytokine analysis of dermal interstitial blister fluid defines local disease mechanisms in systemic sclerosis.
Arthritis Res Ther
, 17
(1)
, Article 73. 10.1186/s13075-015-0575-8.
|
Davies, JC;
Carlsson, E;
Midgley, A;
Smith, EMD;
Bruce, IN;
Beresford, MW;
Hedrich, CM;
... Kelly, S; + view all
(2021)
A panel of urinary proteins predicts active lupus nephritis and response to rituximab treatment.
Rheumatology
, 60
(8)
pp. 3747-3759.
10.1093/rheumatology/keaa851.
|
Esposito, Ilaria;
Kontra, Ioanna;
Giacomassi, Chiara;
Manou-Stathopoulou, Sotiria;
Brown, James;
Stratton, Richard;
Verykokou, Galateia;
... Pfeffer, Paul E; + view all
(2023)
Identification of autoantigens and their potential post-translational modification in EGPA and severe eosinophilic asthma.
Frontiers in Immunology
, 14
, Article 1164941. 10.3389/fimmu.2023.1164941.
|
Gavan, SP;
Bruce, IN;
Payne, K;
Bruce, I;
Lunt, M;
Peek, N;
Geifman, N;
... King, J; + view all
(2022)
Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases.
Value in Health
10.1016/j.jval.2022.07.001.
(In press).
|
Henderson, John;
Naidu, Sharadha Dayalan;
Dinkova-Kostova, Albena T;
Przyborski, Stefan;
Stratton, Richard;
O'Reilly, Steven;
(2021)
The Cell-Permeable Derivative of the Immunoregulatory Metabolite Itaconate, 4-Octyl Itaconate, Is Anti-Fibrotic in Systemic Sclerosis.
Cells
, 10
(8)
, Article 2053. 10.3390/cells10082053.
|
King, J;
Abraham, D;
Stratton, R;
(2018)
Chemokines in systemic sclerosis.
[Review].
Immunology Letters
, 195
pp. 68-75.
10.1016/j.imlet.2017.12.001.
|
McCarthy, EM;
Sutton, E;
Nesbit, S;
White, J;
Parker, B;
Jayne, D;
Griffiths, B;
... British Isles Lupus Assessment Group Biologics Register, BILAGBR; + view all
(2018)
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Rheumatology
, 57
(3)
pp. 470-479.
10.1093/rheumatology/kex395.
|
Moezinia, Carine;
Wong, Valerie;
Watson, James;
Nagib, Lydia;
Lopez Garces, Sandra;
Zhang, Siyu;
Ahmed Abdi, Bahja;
... Stratton, Richard; + view all
(2023)
Autoantibodies Which Bind to and Activate Keratinocytes in Systemic Sclerosis.
Cells
, 12
(20)
, Article 2490. 10.3390/cells12202490.
|
Moezinia, CJ;
Ji-Xu, A;
Azari, A;
Horlick, S;
Denton, C;
Stratton, R;
(2020)
Iloprost for COVID-19-related vasculopathy.
The Lancet Rheumatology
, 2
(10)
e582-e583.
10.1016/S2665-9913(20)30232-0.
|
Morgan-Rowe, L;
Nikitorowicz, J;
Shiwen, X;
Leask, A;
Tsui, J;
Abraham, D;
Stratton, R;
(2011)
Thrombospondin 1 in hypoxia-conditioned media blocks the growth of human microvascular endothelial cells and is increased in systemic sclerosis tissues.
Fibrogenesis Tissue Repair
, 4
, Article 13. 10.1186/1755-1536-4-13.
|
Nikitorowicz-Buniak, J;
Denton, CP;
Abraham, D;
Stratton, R;
(2015)
Partially Evoked Epithelial-Mesenchymal Transition (EMT) Is Associated with Increased TGFβ Signaling within Lesional Scleroderma Skin.
PLoS One
, 10
(7)
, Article e0134092. 10.1371/journal.pone.0134092.
|
Rivellese, F;
Nerviani, A;
Giorli, G;
Warren, L;
Jaworska, E;
Bombardieri, M;
Lewis, MJ;
... Romão, V; + view all
(2023)
Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials.
The Lancet Rheumatology
, 5
(11)
e648-e659.
10.1016/S2665-9913(23)00241-2.
|
Shiwen, X;
Stratton, R;
Nikitorowicz-Buniak, J;
Ahmed-Abdi, B;
Ponticos, M;
Denton, C;
Abraham, D;
... Smith, BD; + view all
(2015)
A Role of Myocardin Related Transcription Factor-A (MRTF-A) in Scleroderma Related Fibrosis.
PLoS One
, 10
(5)
, Article e0126015. 10.1371/journal.pone.0126015.
|
Strange, AP;
Aguayo, S;
Ahmed, T;
Mordan, N;
Stratton, R;
Porter, SR;
Parekh, S;
(2017)
Quantitative nanohistological investigation of scleroderma: An atomic force microscopy-based approach to disease characterization.
International Journal of Nanomedicine
, 12
pp. 411-420.
10.2147/IJN.S118690.
|
Stratton, R;
Shiwen, X;
Martini, G;
Holmes, A;
Leask, A;
Haberberger, T;
Martin, GR;
... Abraham, D; + view all
(2001)
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients.
Journal of Clinical Investigation
, 108
(2)
pp. 241-250.
10.1172/JCI12020.
|
Stratton, R;
Taki, Z;
Denton, C;
Ahmed Abdi, B;
(2020)
Pathogenic Activation of Mesenchymal Stem Cells is induced by the Disease Microenvironment in Systemic Sclerosis.
Arthritis and Rheumatology
, 72
(8)
pp. 1361-1374.
10.1002/art.41267.
|
Trnacevic, A;
Mujkanovic, A;
Al-Salloum, N;
Sakusic, A;
Trnacevic, E;
Jusufovic, E;
Hukic, F;
... Stratton, R; + view all
(2021)
COVID-19 in Northeast Bosnia and Herzegovina and patient’s length of hospitalization.
BMC Infectious Diseases
, 21
(1)
, Article 367. 10.1186/s12879-021-06034-6.
|
Yaseen, B;
Lopez, H;
Taki, Z;
Zafar, S;
Rosario, H;
Abdi, BA;
Vigneswaran, S;
... Stratton, R; + view all
(2020)
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma.
Rheumatology
, 59
(9)
pp. 2625-2636.
10.1093/rheumatology/keaa195.
|